Doppelgerz® Kinder FloraNorm

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.005198.03.15
Date of registration and renewal:31.03.2015
Dosage form: & nbspPowder in sachets with a mass of 1000 mg
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp Supplements promoting normalization and maintenance of normal intestinal microflora
Composition: & nbspBiologically active substances CFU / sachet least: L. rhamnosus - 2,5 * 9 X10, L. reuteri - 2,5H10 * 9 Toxic elements (mg / kg, not more than): lead 1.0 arsenic 0.2 cadmium mercury 0.1 0.03 Microbiological: (coliforms) in 1.0g not allowed E. coli to 5.0g not allowed S.aureus in 1.0g not allowed pathogenic microorganisms including salmonella, 10.0 g not allowed yeast / mold, CFU / g, not more than 50/50 Pesticides, mg / kg, not more than: HCH (sum of isomers) 0.5 DDT and its metabolites 0.02 Heptachlor not allowed not allowed Aldrin Composition: lyophilized live biomass ochnokislyh bacteria, fructooligosaccharides, fructose, E551, natural vanilla flavoring.
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, departments of the trade network as a biologically active food additive - a source of probiotic microorganisms (lactobacilli).
Suggested Usage: & nbsp
Children older than 1 year - 1 sachet per day. The contents of the sachet dissolve package in boiled water at room temperature or be mixed with yogurt or milk taken with food, may be added to cereal or cereal flakes. Do not store in dissolved form. Duration of admission is 10 days. PIf necessary, you can repeat the reception.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Shelf life:2 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding 25 ° C
Research protocols:Expert conclusion of the FGBICU Research Institute of Nutrition No.72 / E-1471 / b-14 of December 18, 2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp24.03.2016
Instructions
Up